Biofrontera Inc.
BFRI
$1.08
-$0.02-1.82%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.64M | -6.65M | -5.32M | -4.20M | -1.40M |
| Total Depreciation and Amortization | 220.00K | 207.00K | 222.00K | 219.00K | 221.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -778.00K | 664.00K | 141.00K | -236.00K | 50.00K |
| Change in Net Operating Assets | -7.46M | 1.96M | 1.92M | 103.00K | 108.00K |
| Cash from Operations | -2.38M | -3.82M | -3.05M | -4.12M | -1.02M |
| Capital Expenditure | 1.00K | 1.00K | -1.00K | -3.00K | -1.00K |
| Sale of Property, Plant, and Equipment | 3.00M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | 3.00M | 1.00K | -1.00K | -3.00K | -1.00K |
| Total Debt Issued | -- | -- | -- | -- | 4.05M |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 2.35M | 8.50M | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -8.50M | 8.50M | -- | -- |
| Cash from Financing | 2.35M | 0.00 | 8.50M | -- | 4.05M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.98M | -3.82M | 5.45M | -4.12M | 3.03M |